TG Therapeutics
TGTX
TGTX
175 hedge funds and large institutions have $1.63B invested in TG Therapeutics in 2020 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 66 increasing their positions, 38 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
74% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 38
20% more funds holding
Funds holding: 146 → 175 (+29)
8.68% more ownership
Funds ownership: 59.28% → 67.96% (+8.7%)
Holders
175
Holding in Top 10
5
Calls
$41.9M
Puts
$23.4M
Top Buyers
| 1 | +$61M | |
| 2 | +$46.8M | |
| 3 | +$29.9M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$29.2M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$26.8M |
Top Sellers
| 1 | -$32.7M | |
| 2 | -$10.8M | |
| 3 | -$7.87M | |
| 4 |
AC
Armistice Capital
New York
|
-$7.56M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$3.96M |